Cormorant Asset Management, LP 的 Form 4 申報
Ambrx Biopharma, Inc.（AMAM），2023/3/16 申報
- 申報編號
- 0000929638-23-000867
- 申報時間
- 2023/3/16 18:04 ET
- 交易日
- 2023/3/14-3/16
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 3 筆非衍生性交易。公開市場買進合計 $1,021 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Cormorant Asset Management, LPCIK 0001583977 | 持股 10% 以上大股東 |
| Chen BihuaCIK 0001599214 | 持股 10% 以上大股東 |
| Cormorant Global Healthcare Master Fund, LPCIK 0001618442 | 持股 10% 以上大股東 |
| Cormorant Private Healthcare Fund III LPCIK 0001817320 | 持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
Represents the weighted average sale price of American Depository Shares ("ADS") purchased in a series of open market transactions on the transaction date at prices ranging from $9.12 to $10.66 per ADS. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of ADS purchased at each price. All of these ADS were purchased by the Master Fund (as defined below).
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents the weighted average sale price of ADS purchased in a series of open market transactions on the transaction date at prices ranging from $10.295 to $11.045 per ADS. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of ADS purchased at each price. All of these ADS were purchased by the Master Fund.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents the weighted average sale price of ADS purchased in a series of open market transactions on the transaction date at prices ranging from $9.65 to $10.35 per ADS. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of ADS purchased at each price. All of these ADS were purchased by the Master Fund.
表 I 有 1 筆交易的價格引用這則附註。